A detailed history of Bank Of Montreal transactions in Schrodinger, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 15,566 shares of SDGR stock, worth $295,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,566
Previous 15,033 3.55%
Holding current value
$295,287
Previous $405,000 25.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$18.65 - $28.5 $9,940 - $15,190
533 Added 3.55%
15,566 $301,000
Q1 2024

May 13, 2024

SELL
$24.74 - $35.13 $12,345 - $17,529
-499 Reduced 3.21%
15,033 $405,000
Q4 2023

Feb 08, 2024

SELL
$21.62 - $37.21 $18,485 - $31,814
-855 Reduced 5.22%
15,532 $556,000
Q3 2023

Nov 01, 2023

SELL
$27.34 - $55.37 $309,461 - $626,733
-11,319 Reduced 40.85%
16,387 $463,000
Q2 2023

Aug 02, 2023

BUY
$26.1 - $49.92 $239,780 - $458,615
9,187 Added 49.61%
27,706 $1.38 Million
Q1 2023

Jun 13, 2024

BUY
$18.09 - $27.61 $121,546 - $185,511
6,719 Added 44.7%
21,752 $572,000
Q4 2022

Feb 01, 2023

SELL
$16.24 - $26.38 $54,533 - $88,584
-3,358 Reduced 15.35%
18,519 $346,000
Q3 2022

Nov 10, 2022

SELL
$23.95 - $34.71 $6.37 Million - $9.23 Million
-265,939 Reduced 92.4%
21,877 $563,000
Q2 2022

Aug 11, 2022

BUY
$21.39 - $35.9 $3.07 Million - $5.16 Million
143,749 Added 99.78%
287,816 $8.23 Million
Q1 2022

May 12, 2022

SELL
$24.84 - $36.12 $290,329 - $422,170
-11,688 Reduced 7.5%
144,067 $5.07 Million
Q4 2021

Feb 11, 2022

SELL
$33.38 - $59.25 $1.62 Million - $2.88 Million
-48,550 Reduced 23.76%
155,755 $5.4 Million
Q3 2021

Nov 12, 2021

SELL
$53.75 - $76.55 $4.65 Million - $6.63 Million
-86,568 Reduced 29.76%
204,305 $11.2 Million
Q2 2021

Aug 12, 2021

BUY
$59.02 - $78.8 $17.2 Million - $22.9 Million
290,873 New
290,873 $23 Million

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.18B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.